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Abstract
MDMA causes selective depletion of serotonergic terminals in experimental animals and the consequent
decrease in synaptic 5-HT may, inter alia, increase impulsivity. To study the eﬀects of MDMA upon brain
function, the behaviour of male Dark Agouti rats exposed to MDMA (15 mg/kg i.p.), two 5-HT1B agonists
(CGS-12066A and CP-94,253, both 5 mg/kg i.p.) or saline were investigated in the resident-intruder
test. Studies were performed in drug-naive rats and also in rats exposed to MDMA (15 mg/kg i.p.) 21 d
earlier. In parallel experiments the functional neuroanatomy of MDMA eﬀects were assessed using
2-deoxyglucose imaging of local cerebral metabolic rate of glucose utilization (LCMRGlu) and neurotox-
icity was assessed by measuring [3H]paroxetine binding. There was no signiﬁcant diﬀerence in aggressive
behaviour (biting, boxing, wrestling and their latencies) between drug-naive rats and rats previously
exposed to MDMA 21 d earlier, despite reduced social behaviour, decreased LCMRGlu in several brain
areas involved in aggression, and reductions in paroxetine binding by 30–60% in the forebrain. CGS-
12066A, CP-94,253 and acute MDMA produced marked decreases in aggressive behaviours, especially in
biting, boxing and kicking found in drug-naive rats. In animals previously exposed to the drug, acute anti-
aggressive eﬀects of MDMA were, in general, preserved as were MDMA-induced increases in LCMRGlu.
Our studies provide evidence that in the resident-intruder test, where social isolation is a requirement,
aggressive behaviour and acute anti-aggressive eﬀects of MDMA and 5-HT1B receptor agonists remain
intact 3 wk after a single dose of the drug despite signiﬁcant damage to the serotonergic system.
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Introduction
The ring-substituted amphetamine derivative (¡)-
3,4-methylendioxymethamphetamine (MDMA; ec-
stasy) has become a widely abused psychoactive
drug among young people and is popular for its
mood-enhancing eﬀects (Bond et al., 2004 ; Parrott,
2001 ; Steele et al., 1994). In the central nervous system
(CNS), MDMA has characteristic, and well-docu-
mented two-phase eﬀects upon monoaminergic sys-
tems. First, shortly after administration, there is an
acute release of serotonin (5-HT) (Green et al., 2003 ;
Mechan et al., 2002 ; Shankaran and Gudelsky, 1998),
dopamine (DA) and norepinephrine (Colado et al.,
1999 ; Fitzgerald and Reid, 1990 ; Rothman et al., 2001 ;
Yamamoto and Spanos, 1988). Second, in the brains of
rodents and non-human primates, MDMA causes a
long-term reduction in 5-HT, 5-hydroxyindolacetic
acid (5-HIAA) concentration and 5-HT transporter
density. Most investigators interpret the latter as a
neurotoxic eﬀect that involves the serotonergic axons
and depletion of terminals (Battaglia et al., 1987 ;
Colado et al., 1993 ; Green et al., 2003 ; Ricaurte et al.,
2000 ; Schmidt, 1987).
There is strong evidence that 5-HT plays a crucial
role in the regulation of impulsivity and aggression
(Berman et al., 1997 ; Morgan, 1998), although other
neurotransmitters, notably DA and GABA have also
been linked to human and animal aggression (Miczek
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et al., 2002 ; Nelson and Chiavegatto, 2001). 5-HT re-
lease, or high 5-HT levels, are generally correlatedwith
low aggressiveness (Nelson and Chiavegatto, 2001;
van der Vegt et al., 2003). In contrast, serotonergic
dysfunction, as deﬁned by low cerebrospinal ﬂuid
(CSF) levels of 5-HT and 5-HIAA, has been associated
with increased aggression (Clark and Neumaier, 2001;
Scearce-Levie et al., 1999a).
Acute administration of MDMA has anti-aggressive
eﬀects both in humans and inmice (Curran et al., 2004;
Miczek and Haney, 1994), presumably due to 5-HT
release although increased impulsivity and aggression
has been found amongst humans who report previous
chronic heavy ecstasy use (Bond et al., 2004 ; Gerra
et al., 1998 ; Morgan, 1998 ; Parrott et al., 2000).
Although it is tempting to speculate that increased
aggression in human users is a symptom of MDMA-
induced neurotoxicity, the supporting evidence,
whilst growing (Curran, 2000 ; Reneman et al., 2001;
Ricaurte et al., 2000) is not yet totally compelling. It is
possible that symptomatic neurotoxicity may be limi-
ted to heavy users, and/or to particularly susceptible
individuals (McCann and Ricaurte, 1991), in which
vulnerability may be genetically (Roiser et al., 2005) or
environmentally determined. This may go some way
towards explaining why MDMA-induced seroton-
ergic neurotoxicity is not fully established in humans
and shows great inter-individual variation. None-
theless, it is perhaps timely to assess whether MDMA
treatment in rats, within the dose range which causes a
well-established long-term serotonergic deﬁcit, is
likely to elicit changes in aggressive behaviour and
impulsivity which may parallel similar behavioural
changes in humans.
The drug-induced long-term serotonergic loss may
evoke functional changes to 5-HT receptors which, as
well as other physiological functions in the brain, may
play a role in modulating aggression and related be-
haviours. The 5-HT1B receptor in particular is thought
to have such a function, and a number of pharmaco-
logical studies have suggested that 5-HT1B receptor
activation reduces aggression (Clark and Neumaier,
2001 ; Muehlenkamp et al., 1995 ; Scearce-Levie et al.,
1999a). Moreover, it is known that CGS-12066 and CP-
94,253, two selective 5-HT1B receptor agonists, have an
anti-aggressive eﬀect (Bell et al., 1995 ; Clark and
Neumaier, 2001; Fish et al., 1999).
In our previous studies, we have reported that acute
MDMA results in a generalized increase in metabolic
activity in many brain areas, while in the longer term,
chronic hypoactivity has been described (Balogh et al.,
2004 ; Quate et al., 2004). These eﬀects are more
widespread than would be predicted solely on the
basis of serotonergic terminal distributions, reﬂecting
the highly integrated nature of cerebral function, and
may help in identifying brain areas that are involved
in the control of aggressive behaviour both directly
and indirectly. Despite the evidence of these and
other studies on the acute eﬀects, few studies have
investigated the eﬀects of MDMA on behaviour in
animals previously exposed to the drug. In this study,
we aimed to reassess previous results showing that
acute MDMA decreases aggressive-type behaviour,
and to test the hypothesis that 3 wk after a single,
neurotoxic dose of MDMA, there would be a signiﬁ-
cant increase in aggression and impulsivity, an
attenuation of the acute eﬀects of further MDMA
exposure, and changes in 5-HT1B receptor function.
To these ends, the aim of this work was to examine
the acute and long-term eﬀects of a single dose of
MDMA upon aggression, in drug-naive rats and rats
previously exposed to the same dose 3 wk earlier,
using the resident-intruder aggression test. A second
set of experiments was designed to assess possible
MDMA-evoked changes in 5-HT1B receptor function
in rats previously exposed to the drug, by measuring
the acute eﬀects of the 5-HT1B selective agonist CGS-
12066 (and its congener CP-94,253) upon aggression.
In parallel to the behavioural studies we examined the
acute and long-term eﬀects of MDMA upon brain
metabolism, in drug-naive and MDMA-pretreated
animals, by measuring the local cerebral metabolic
rate of glucose utilization (LCMRGlu), in brain areas
relevant to the regulation of aggression. In addition,
[3H]paroxetine binding to 5-HT transporter sites was
measured by autoradiography in order to provide
evidence for long-term serotonergic changes in fore-
brain areas. These transporter sites are localized to
5-HT terminals and reductions in radioligand binding
have been shown to correlate with anatomical evi-
dence of terminal depletion (Battaglia et al., 1987).
Methods
Animals
All animal experiments were carried out in accordance
with the European Communities Council Directive of
24 November 1986 (86/609/EEC) and the National
Institutes of Health ‘Principles of Laboratory Animal
Care’ (NIH Publication no. 85-23, revised 1985). In
addition, speciﬁc national laws were adhered to [the
Hungarian Governmental Regulation about animal
studies of 31 December 1998 and the United Kingdom
Animals (Scientiﬁc Procedures) Act, 1986] ; permission
was also obtained from local ethical committees.
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Male Dark Agouti (DAg) rats (Harlan, Olac Ltd,
Shaw’s Farm, Blackthorn, Bicester, Oxon, UK, aged
4–5 wk andweighing 50–80 g upon arrival), were used
in the experiments. Animals were housed under stan-
dard 12-h light–dark conditions (lights on 06:00
hours), with standard rat chow and water freely
available (Balogh et al., 2004). Ambient temperature in
the animal house was maintained at 21¡1 xC. MDMA
or saline pretreatment was administered at the age of
7 wk and the resident-intruder test was carried out
3 wk later when the resident animals were 10 wk old
(weight 215¡2.50 g) and the intruders were 5–6 wk
old (weight 80.65¡1.35 g). To establish the resident
status of the rats, these animals were housed singly for
the ﬁnal 2 wk prior to the test (Stuerenburg et al.,
2002). The same conditions were replicated as closely
as possible for animals used in the measurement of
LCMRGlu, with the exception that animals were
group-housed until the day of the ﬁnal experiment.
Drugs
(¡)3,4-methylenedioxymethamphetamine hydrochlor-
ide (MDMA, certiﬁed reference compound, purity
>99.5%) was provided by Sanoﬁ-Synthelabo-Chinoin,
Budapest, Hungary. The MDMA was dissolved in
saline and animals injected with a dose equivalent to
15 mg/kg free base. 5-propoxy-3-(1,2,3,6-tetrahydro-
4-pyridinyl)-1H-pyrrolo[3,2-b]pyridine hydrochloride
(CP-94,253; Tocris, Bristol, UK) was dissolved in dis-
tilled water at a dose of 5 mg/kg. 7-triﬂuoromethyl-
4(4-methyl-1-piperazinyl)-pyrrolo[1,2-a]quinoxaline
maleate (CGS-12066A; Sigma RBI, Steiheim, Germany)
was dissolved in 10% HPCD (2-hydroxypropyl-b-
cyclodextrin ; Fluka, Buchs, Switzerland).
Control rats received an injection of 0.9% NaCl
(saline) or 10% HPCD (vehicle for CGS-12066A) in a
volume of 1 ml/kg. All drugs were administered
intraperitoneally (i.p.).
Experimental procedures
Resident-intruder test
Resident rats were pretreated with MDMA (15 mg/
kg) or saline on a single occasion, 3 wk prior to the
acute drug administrations (MDMA, CGS-12066,
CP-94,253), which occurred 20 min prior to the intro-
duction of the intruder to the home cage of the resi-
dent rat (Fish et al., 1999). Treatment groups consisted
of 6–10 animals in the resident-intruder test. Each rat
was tested only once.
The resident-intruder aggression test was conduc-
ted by introducing a small (intruder) rat into the cage
of a larger (resident) rat (Muehlenkamp et al., 1995).
The behaviour of the animals was recorded on video-
tape for 15 min immediately after the introduction of
the smaller animal into the cage (Holmes et al., 2002).
The record was scored manually at a later time using a
computer program designed for the purpose, as pre-
viously described by us (Kantor et al., 2000). The data
were calculated from the raw scores made by a trained
observer and these were included in the results.
The following behavioural elements were scored:
biting, boxing, kicking were scored and classiﬁed as
impulsive aggressive behaviours, and the incidence of
each parameter, as well as their sum were calculated.
The latency of each behaviour (the time elapsed until
the ﬁrst event) was also recorded. An additional par-
ameter, namely the latency of ﬁrst impulsive aggress-
ive behaviour (biting, boxing, and kicking) was also
recorded. This was deﬁned as the time elapsed until
the appearance of the ﬁrst element irrespective of
whether this constituted biting or boxing or kicking.
Duration and latency of wrestling were also scored
and calculated. Within this parameter pushing and
dominant posture were also included.
Duration of anogenital sniﬃng, grooming of the
intruder, over-crawling and under-crossing were
included and summarized within the social behav-
iours. From these behaviours, grooming the intruder
was also analysed separately, scored and calculated.
The motor activity of each resident animal was
observed and scored in each of the three 5-min periods
and a single numerical score was assigned to each rat,
for each period. Scoring was based on a ﬁve-point
scale (0–4) ; 0 indicating lack of movement, and 4
indicating continuous motor activity. The three scores
from each of the periods were summed, yielding a
score in the range 0–12 for each resident animal.
Exploratory behaviour was scored in a similar way
to locomotor activity, using a ﬁve-point (0–4) scale.
Scoring recorded the frequency of the following
events : rearing, sniﬃng, exploration of the home cage.
For statistical analysis, STATISTICA 6.0 (Statsoft Inc.,
Tulsa, OK, USA) and GraphPad Prism (GraphPad
Software Inc., San Diego, CA, USA) software were
used. Tests for homogeneity of variances indicated
that variances for duration of wrestling, social behav-
iour and grooming were not homogenous and thus,
the Kruskal–Wallis non-parametric test was performed
for these parameters while incidences and latencies of
events, scores of motor activity and exploratory be-
haviour were analysed using non-parametric tests.
Where statistical diﬀerences were detected, further
comparisons were performed by Mann–Whitney U
tests. For the analysis of pretreatmentrtreatment
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interactions two-way analysis of variance (ANOVA)
was used for all parameters.
Measurement of LCMRGlu
On the day of the experiment, 21 d after pretreatment
with either MDMA or saline, rats were anaesthetized
with halothane (maintained at 1% in a gas mixture of
70% nitrous oxide, 30% oxygen) and polythene can-
nulae were inserted into both femoral arteries (to
allow sampling of arterial blood and monitoring of
arterial blood pressure), and both femoral veins (for
the injection of radiolabelled tracers and barbiturate at
the termination of the experiment). An additional
cannula was inserted i.p. via a trocar and held in place
with a ﬁne suture to allow the i.p. injection of MDMA.
The incision sites were inﬁltrated with local anaes-
thetic and the wounds sutured closed. A loose-ﬁtting,
individually moulded plaster cast was applied around
the hindquarters and pelvis and secured to a weighted
platform. Thus, lightly restrained and supported, a
rectal temperature probe was inserted and anaesthesia
was discontinued. Animals were allowed to recover
from anaesthesia for at least 2 h prior to further
experimental manipulation.
The measurement of LCMRGlu was performed
using the fully quantitative [14C]-2-deoxyglucose
(Sokoloﬀ et al., 1977) autoradiographic technique. The
measurement protocols were in complete accordance
with the methodology as originally published
(Sokoloﬀ et al., 1977) and as previously detailed from
this laboratory (Kelly et al., 1995 ; Quate et al., 2004).
On the ﬁnal experimental day, rats from both pre-
treatment groups were injected with MDMA (15 mg/
kg; saline pretreatment+acute MDMA group and
MDMA pretreatment+acute MDMA) or saline as
control (saline group) via the in-dwelling i.p. cannula.
Fifteen minutes later, the measurement of LCMRGlu
was initiated with the intravenous injection of [14C]-2-
deoxyglucose (30 mCi in 0.75 ml saline) administered
at a constant rate over the ﬁrst 30 s of the experiment.
Over the subsequent 45 min, a total of 14 timed arterial
blood samples were collected at pre-determined in-
tervals which were centrifuged in order to separate the
plasma. Aliquots of plasma were removed for the
determination of plasma 14C concentrations (20 ml) and
glucose levels (10 ml) by liquid scintillation analysis
and semi-automated glucose oxidase assay (Beckman,
High Wycombe, Bucks, UK) respectively. At the end
of the measurement period the rats were killed with a
rapid intravenous injection of sodium pentobarbitone
and the brains were immediately dissected out intact,
and rapidly frozen in pre-cooled 2-methylbutane
(x45 xC). Frozen brains were mounted onto specimen
holders and stored at x70 xC until sectioned in a
cryostat for the preparation of autoradiograms.
Sections adjacent to those used for autoradiographic
measurement of LCMRGlu were thaw-mounted onto
gelatine-covered glass slides and stored atx70 xC for
subsequent [3H]paroxetine autoradiographic binding
analysis of 5-HT uptake sites according to the protocol
described by De Souza and Kuyatt (1987) but with the
addition of two 5-min prewashes in buﬀer [50 mM
Tris–HCl, 120 mMNaCl, 5 mM KCl (pH 7.7) at 23 xC] to
remove 14C tracers from the tissue (De Souza and
Kuyatt, 1987 ; Sharkey et al., 1991). Sections were then
incubated in the same buﬀer containing a saturating
concentration (250 pM) of [3H]paroxetine (speciﬁc
activity 23.1 Ci/mmol ; New England Nuclear DuPont,
Stevenage, UK). Non-speciﬁc binding was deﬁned in
adjacent sections by [3H]paroxetine binding in the
presence of 4 mM citalopram. Following incubation, the
sections were washed in buﬀer, dipped in deionized
water and rapidly dried under a stream of cold air.
The slides, together with a set of [3H]-containing
standards (Amersham Microscales, Amersham,
Bucks, UK) were apposed to X-ray ﬁlm (Amersham
Hyperﬁlm) in a light-tight cassette and stored at
x70 xC for 4–6 wk. The ﬁlms were processed accord-
ing to the manufacturer’s instructions.
Analysis of [14C]-2-deoxyglucose and [3H]parox-
etine autoradiograms was performed using a com-
puter-based image analysis system (MCID/M5+).
Local tissue isotope concentrations were derived
from the optical density of autoradiographic images
of brain tissue, relative to appropriate [14C]- or [3H]-
containing standards. LCMRGlu was calculated using
the operational equation for the technique (Sokoloﬀ
et al., 1977), and radioligand binding was calculated
from the tissue concentrations and the speciﬁc activity
of the [3H]paroxetine. Data were analysed using
Student’s t test for grouped data with acceptable levels
of signiﬁcance set at p<0.05.
Results
Long-term eﬀects of MDMA
In rats exposed to MDMA 3 wk prior to the exper-
iment there were no signiﬁcant diﬀerences in the
incidence of biting, boxing, the sum of biting, boxing
and kicking or in the latencies of the three combined
measures, and neither was there any diﬀerence in the
duration of wrestling, or its latency compared to the
control, drug-naive group (Figure 1). There was,
however, a signiﬁcant increase in kicking (H=18.912,
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Figure 1.Acute eﬀects of MDMA (15 mg/kg) upon incidence of biting (a), boxing (b), kicking (c), total incidence (d) and latency (e) of biting, boxing, kicking, duration (f) and latency
(g) of wrestling, duration of social behaviour (h) and grooming (i) in drug-naive rats and in rats exposed to MDMA 3 wk earlier. Each group consisted of seven animals.
Pretreatmentrtreatment interactions of ANOVA are signiﬁcant where noted. * Signiﬁcantly diﬀerent from the appropriate control with the same pretreatment (p<0.05).
# Signiﬁcantly diﬀerent from the saline-pretreated group with the same acute treatment (p<0.05). Sal, Saline.
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p<0.05, Figure 1) and a small decrease in grooming
and social behaviour (H=24.473, p<0.05 and
H=24.340, p<0.01, for grooming and social behaviour
respectively ; Figure 1). Locomotor activity and
exploratory behaviour were also unchanged in rats
pretreated with MDMA (Figure 2).
Acute eﬀects of MDMA in drug-naive rats and in rats
previously exposed to MDMA
In drug-naive rats, acute MDMA treatment caused
massive decreases in all measures of aggressive
behaviour, namely, incidence of biting (H=12.749,
p<0.01), boxing (H=19.829, p<0.001), kicking
(H=18.912, p>0.05), and both the sum (H=21.602,
p<0.001) and latency of the three measures combined
(H=15.832, p<0.001). The duration of wrestling
(H=21.237, p<0.01) was also reduced and subs-
equently, its latency was increased (H=20.350,
p<0.01 ; Figure 1). Furthermore, a marked reduction
was also observed in other social behaviours
(H=24.340, p<0.001) and grooming (H=24.473,
p<0.001, Figure 1) When young intruder animals
were placed into the residents’ home cages, both loco-
motor activity and exploratory behaviour of saline-
pretreated resident rats was markedly increased. This
was not exclusively restricted to exploration of the
intruder animal, but also the home cage itself was
intensively explored. Increases in locomotor activity
(H=20.541, p>0.05) and exploratory behaviour
(H=20.957, p>0.05, Figure 2) were attenuated in
saline-pretreated animals after acute exposure to
MDMA. In the MDMA-pretreated rats, all acute eﬀects
of MDMA were preserved (Figures 1 and 2). The pre-
treatmentrtreatment interaction was signiﬁcant only
for the duration of social behaviours (F1, 24=6.394,
p=0.0008) and grooming (F1, 24=14.824, p=0.018).
Acute eﬀects of CGS-12066 and CP-94,253 in
drug-naive rats and in rats previously exposed
to MDMA
Acute treatment with CGS-12066 reduced the inci-
dence of biting (H=8.029, p<0.01) and boxing
(H=12.372, p<0.01), the sum of biting, boxing and
kicking (H=15.792, p<0.01), and the duration of
wrestling (H=8.298, p<0.01) in drug-naive animals
(Figure 3). Latencies of biting, boxing and kicking
(H=12.022, p<0.01) were increased by the drug.
Interestingly, the eﬀects of the drug on biting, boxing
and kicking were more robust than the eﬀects upon
wrestling. The compound also signiﬁcantly decreased
grooming (H=11.617, p<0.01) and the sum of all non-
aggressive social behaviour (H=6.107, p<0.05 ; Figure
3). In contrast to the eﬀects of acute MDMA, CGS-
12066 signiﬁcantly increased the motor activation
elicited by the presence of the intruder (H=14.938,
p<0.01 ; Figure 4) and exploratory behaviour was also
increased (H=22.471, p>0.05). The locomotor scores
presented here reﬂect the time spent in locomotor
activity. It was observed, however, that all motor
activities, including exploration, social behaviour and
diﬀerent manifestations of aggressive behaviour were
all performed at a noticeably increased speed in the
presence of CGS-12066.
In rats previously exposed to MDMA, the acute
eﬀects of CGS-12066 were preserved with respect to
most parameters (biting, boxing, duration of wrestling
and grooming) although some of these, such as the
eﬀects on kicking, the sum of biting, boxing and kick-
ing, as well as their latencies were more weakly
expressed (Figure 3). In contrast, CGS-12066 treat-
ment enhanced locomotor activity (H=14.938, p<0.05)
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Figure 2. Acute eﬀects of MDMA (15 mg/kg) on motor
activity and exploratory behaviour in drug-naive rats and in
rats exposed to MDMA 3 wk earlier. Each group consisted of
seven animals. * Signiﬁcantly diﬀerent from the appropriate
control with the same pretreatment, (p<0.05). Sal, Saline.
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Figure 3. Acute eﬀects of CGS-12066 (5 mg/kg) upon incidence of biting (a), boxing (b), kicking (c), total incidence (d) and latency (e) of biting, boxing, kicking, duration (f) and
latency (g) of wrestling, duration of social behaviour (h) and grooming (i) in drug-naive rats and in rats exposed to MDMA 3 wk earlier. Each group consisted of 6–10 animals
[Sal+Sal (n=8), Sal+CGS (n=10), MDMA+Sal (n=6), MDMA+CGS (n=10)]. * Signiﬁcantly diﬀerent from the appropriate control with the same pretreatment (p<0.05).
# Signiﬁcantly diﬀerent from the saline-pretreated group with the same acute treatment (p<0.05). Sal, Saline ; Veh, vehicle.
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and exploratory behaviour (H=22.471, p<0.001) in
MDMA-pretreated animals (Figure 4). Signiﬁcant
pretreatmentrtreatment interaction was found in
exploratory behaviour (F1,32=4.947, p=0.033).
The eﬀects of CP-94,253 were, in general, compar-
able to those of CGS-12066, with similar interactions
with MDMA pretreatment (data not shown).
Acute and long-term eﬀects of MDMA on LCMRGlu
The eﬀects of acute MDMA on LCMRGlu in those brain
areas thought to be involved in aggression were meas-
ured in both drug-naive rats and in rats treated with
MDMA 3 wk earlier. In rats pretreated with MDMA,
and treated acutely with saline, there was a general
trend towards decreased LCMRGlu (Table 1), ranging
from x3% in central amygdala (not signiﬁcant) to
x25% in medial amygdala (p<0.05). Other signiﬁcant
decreases were observed in cingulate cortex, lateral
septal nucleus, mediodorsal thalamic nucleus, peri-
aqueductal grey matter, locus coeruleus and median
raphe nucleus. In two areas of the brain, the hypo-
thalamic attack area and the arcuate nucleus,
LCMRGlu was found to be increased in MDMA-
pretreated rats, but these eﬀects were small (9% and
6% respectively) and not statistically signiﬁcant.
In keeping with previous observations, acute treat-
ment with MDMA resulted in widespread increases in
LCMRGlu in drug-naive rats (Figure 5). The only
exceptions were found in the hypothalamic attack
area (x9%), anterior hypothalamic area (x4%) and
median raphe (x5%) but the decreases in LCMRGlu in
these areas were relatively small and not signiﬁcant.
However a more substantial decrease in the cingulate
cortex (x20%) was signiﬁcantly diﬀerent from that in
rats treated acutely with saline.
The increases in LCMRGlu elicited by acute MDMA
in rats previously exposed to the drug were more
widespread, and included areas in which the drug had
been shown to decrease LCMRGlu in previously drug-
naive rats (most notably median raphe, anterior
hypothalamus and cingulate cortex). Only in the
hypothalamic attack area were decreases in LCMRGlu
(of similar magnitude) found in response to acute
MDMA, irrespective of pretreatment. Elsewhere in the
brain, there was evidence that the response to acute
MDMA was potentiated by MDMA-pretreatment
(Figure 5). This potentiation was most marked in the
lateral septal nucleus (+30% vs. +70%) and locus
coeruleus (+15% vs.+55%).
Long-term eﬀects of MDMA on [3H]paroxetine
binding
[3H]paroxetine binding was measured in brain tissue
from animals exposed to saline or MDMA 3 wk pre-
viously (Table 2). No signiﬁcant eﬀects of MDMA
were observed in the median raphe nucleus (2%),
although signiﬁcant reductions in binding were
observed in the piriform cortex (x38%), cingulate
cortex (x59%), septal nucleus (x20%), amygdala
(x31%).
Discussion and conclusion
Acute MDMA treatment decreased aggressive-type
behaviour as measured with the resident-intruder test,
and the anti-aggressive eﬀects of 5-HT1B agonists were
similar to those of MDMA. Acute MDMA treatment
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Figure 4. Acute eﬀects of CGS-12066 (5 mg/kg) on motor
activity and exploratory behaviour in drug-naive rats and in
rats exposed to MDMA 3 wk earlier. Each group consisted of
6–10 animals [Sal+Sal (n=8), Sal+CGS (n=10),
MDMA+Sal (n=6), MDMA+CGS (n=10)]. * Signiﬁcantly
diﬀerent from the appropriate control with the same
pretreatment (p<0.05). # Signiﬁcantly diﬀerent from the
saline-pretreated group with the same acute treatment,
(p<0.05). Sal, Saline.
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increased brain metabolism in several areas including
those involved in the regulation of aggression.
Signiﬁcant long-term decreases in paroxetine binding
and brain metabolism were found in many brain
areas, 3 wk after MDMA administration, although
at this time-point aggressive-type behaviour was
unaltered. Contrary to expectation, increases in brain
metabolism induced by acute MDMA were not
diminished in rats previously exposed to the drug.
The anti-aggressive eﬀects of 5-HT1B-agonists in
MDMA-pretreated rats were, in general, preserved
and only modest changes were observed.
Table 1. Local cerebral metabolic rate of glucose utilization (LCMRGlu) in saline and MDMA (15 mg/kg i.p.)
pretreated animals
Brain area
LCMRGlu (mmol/100 g . min)
Saline pretreatment
+acute saline
MDMA pretreatment
+acute saline % change
Median raphe nucleus 87¡3 70¡2* x20
Locus coeruleus 62¡2 49¡2* x21
Periaqueductal grey 60¡2 48¡2* x20
Mediodorsal thalamic nucleus 101¡4 83¡3* x18
Central amygdala 68¡7 66¡3 x3
Medial amygdala 53¡5 40¡2* x25
Arcuate nucleus 54¡2 57¡1 6
Hypothalamic attack area 55¡2 60¡4 9
Anterior hypothalamic area 52¡1 49¡2 x6
Medial preoptic area 50¡3 45¡1 x10
Bed nucleus of the stria terminalis 52¡2 45¡2 x13
Lateral septal nucleus 60¡3 50¡2* x17
Medial septal nucleus 48¡2 44¡2 x8
Piriform cortex 52¡4 48¡1 x8
Cingulate cortex 113¡4 91¡2* x19
Data presented as mean¡S.E.M. Percentages are diﬀerences from saline control.
* Signiﬁcantly diﬀerent from saline control group (p<0.05). Each group consisted of seven animals.
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Figure 5. Acute eﬀects of MDMA upon LCMRGlu in drug-
naive animals and in animals previously exposed to MDMA.
Data are presented as mean percentage change from
control¡S.E.M. * Signiﬁcantly diﬀerent from saline pretreated
animals (p<0.05, Mann–Whitney U test). Each group
consisted of seven animals.&, MDMA pretreatment+acute
MDMA;%, saline pretreatment+acute MDMA.
Table 2. [3H]Paroxetine binding in animals exposed to either
saline or MDMA (15 mg/kg) 3 wk previously
Brain area Saline MDMA Lesion %
Neocortex
Piriform cortex 64¡5 40¡7* x38
Cingulate cortex 66¡7 27¡4* x59
Septal nucleus 64¡4 51¡3* x20
Amygdala 210¡15 144¡10* x31
Median raphe nucleus 170¡16 173¡21 2
Data are presented as mean binding density (fmol/mg
tissue)¡S.E.M.
Each group consisted of seven animals.
* Signiﬁcantly diﬀerent from saline control group (p<0.05).
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Acute eﬀects of MDMA on aggression and LCMRGlu
The data from the present study support previous
observations that acute MDMA treatment decreases
aggressive-type behaviour in rats, as measured in the
resident-intruder test (Miczek et al., 1994 ; Navarro
et al., 1999 ; Verheyden et al., 2002), as well as in
human abusers (Curran et al., 2004). However, in the
present study there were some diﬀerences in the
eﬀect of MDMA upon the separate parameters of
aggression, for example in the frequency of biting,
boxing and kicking. Closer examination of the data
reveals that this is due, in the main, to diﬀerences in
the manifestation of attack between individuals, with
some animals preferring to kick, while others showed
a greater tendency to box or bite.
Interestingly, changes were also found in other
parameters not closely related to aggression. Intro-
ducing an intruder to the home cage usually results in
marked increases in locomotor activity and explora-
tory behaviour from the resident animal, but this
hyperlocomotion was signiﬁcantly attenuated by
acute MDMA treatment (Figure 2). Similarly, signiﬁ-
cant decreases were found in social behaviour
(Figure 1). Thus, it appears that if the resident animal
is treated with MDMA in advance of the introduction
of the intruder, it is less aﬀected by the presence of the
intruder animal. In parallel studies on animals outwith
the behavioural paradigm, i.e. where no stimulus or
target for aggressive behaviour is available, MDMA-
induced increases in local cerebral metabolic rate were
found in several brain regions that regulate (either
activate or inhibit) aggression, and also in other
regions that regulate many other physiological func-
tions. This is perhaps not surprising given the wide-
spread anatomical distribution of serotonergic
projections, and the possible involvement of both
dopaminergic and noradrenergic systems in the
pharmacological response to MDMA.
The long-term eﬀects of MDMA on aggression,
LCMRGlu and paroxetine binding
In our study, MDMA was administered to Dark
Agouti rats at a dose of 15 mg/kg. Although there are
considerable strain diﬀerences in the susceptibility to
MDMA-induced long-term serotonergic depletion,
many authors suggests that a single, 15 mg/kg injec-
tion of MDMA in rats may more accurately model the
possible exposure to the drug in humans, particularly
when pharmacokinetic scaling is applied to body size
and basal metabolic rate (Colado and Green, 1995;
Malpass et al., 1999). In contrast, it is less likely that
previously used models in which, typically, rats are
treated with a higher dose (20 mg/kg) twice a day for
four consecutive days adequately reﬂect human
experience. Moreover, Dark Agouti rats show de-
creased microsomal CYP2D6 isoenzyme activity,
which plays an important role in the metabolism of
MDMA. As a consequence, the Dark Agouti rat is
considered to be a poor or moderate metabolizer of the
drug with MDMA pharmacokinetics that are similar
to those which may be found in particularly vulner-
able human users (Balogh et al., 2004 ; O’Shea et al.,
1998 ; Quate et al., 2004). Such users might represent a
genetically deﬁned human sub-population in which
clinical complications are more likely to occur.
In this study, signiﬁcant decreases in paroxetine
binding of between 30% and 60% were found in the
neocortex, septal nucleus and amygdala, but not in the
median raphe nucleus, 3 wk after a single exposure to
MDMA. This ﬁnding is totally in agreement with
previous data, which showed that a similar MDMA
treatment caused long-term serotonergic depletion in
the forebrain of Dark Agouti rats (Colado et al., 1998;
O’Shea et al., 1998). Of particular interest in the context
of our behavioural data, is the observation of
decreased binding in some areas of the brain known to
be involved in the regulation of aggression and
impulsivity. However, despite the deleterious eﬀect of
MDMA on the serotonergic system, and previous
evidence that depletion of 5-HT in the amygdala
facilitates aggressive behaviour (Morgan, 2000),
the present study indicates that manifestations of
aggressive behaviours was not abnormal in rats
pretreated with MDMA 3 wk earlier. For example the
animals did not exhibit attacks to vulnerable areas on
the target intruder, which is considered a pathological
form of aggression (Halasz et al., 2002a,b). There was,
however, evidence from our metabolic mapping
studies that, in the resting state at least, MDMA
pretreatment did result in altered functional activity in
some elements of the amygdala, indicating that the
treatment was not without eﬀect.
The lack of evidence for increased aggression in this
test may be explained in many ways. First, the level of
aggression exhibited by rats in this test is normally
relatively high. It could be diﬃcult to detect further
small increases in an already high aggressive state,
which is described as an essential factor in this test
paradigm (Navarro and Maldonado, 1999). Further-
more, chronic social isolation, which is necessary to
confer resident status, has been reported to decrease
5-HT levels in forebrain areas in the long-term (Dalley
et al., 2002 ; Fulford and Marsden, 1998 ; Robbins et al.,
1996), and indeed this could be one explanation for the
increased baseline aggression in the resident-intruder
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test. A further decrease in 5-HT content as a result
of MDMA pretreatment may not elicit any further
increase in aggression. Moreover, in keeping with
these behavioural ﬁndings, LCMRGlu was signiﬁ-
cantly decreased 3 wk after MDMA administration,
albeit in the absence of aggression-inducing stimuli.
The decrease in metabolismwas found in several brain
areas, including those thought to mediate aggressive
behaviour, and also in those that inhibit aggression.
It is conceivable that the integration of these
inhibitory and disinhibitory eﬀects could confound
our measures of aggression, or alternatively represent
a compensatory mechanism to normalize function.
Human studies that have sought to identify
MDMA-induced abnormalities are diﬃcult to inter-
pret due to inherent methodological complications
with retrospective studies. These complications in-
clude inaccurate reporting of the doses MDMA taken,
the duration and frequency of drug use, and non-
reporting of the concurrent use of other substances,
licit or illicit (Green et al., 1995 ; Morgan, 2000).
However, some studies have demonstrated an in-
crease in aggression and impulsivity in heavy ecstasy
users (Bond et al., 2004 ; Gerra et al., 1998, 2000), which
may suggest that in the long term MDMA might in-
crease aggression in humans. However, no signiﬁcant
increase was found in light/moderate users (Morgan,
1998 ; Parrott, 2000) and earlier studies in humans have
found that, although aggression increases 4 d after
exposure to MDMA, there is no signiﬁcant increase in
aggressive behaviour 7 d after the exposure (Curran
et al., 2004). Only McCann et al. (1994) reported that
heavy ecstasy users had lower aggression than control
participants.
Eﬀects of a previous MDMA treatment on
MDMA-induced increases in LCMRGlu and on the
behavioural eﬀects of acute MDMA, CGS-12066
and CP-94,253 administration
Our results indicate that all of the acute behavioural
eﬀects of MDMA were preserved when a neurotoxic
MDMA pretreatment was applied 3 wk before the test.
The MDMA-induced depletion of serotonergic ter-
minals, for which our [3H]paroxetine-binding data
provide positive evidence in this study, could be
assumed to reduce the availability of releasable 5-HT,
and might be expected to result in an attenuated
anti-aggressive response to acute MDMA treatment.
However, these anti-aggressive eﬀects or any possible
changes caused by 5-HT depletion, may possibly be
masked by the general inhibitory behaviour which is
unaﬀected by neurotoxic MDMA pretreatment.
Acute MDMA caused a signiﬁcantly greater
increase in brain metabolism in pretreated rats
compared to saline-treated animals. This could be
explained in part by the lower baseline activity in the
brain areas examined (as stated previously), so that
metabolic rates after acute MDMA administration
were largely similar in drug-naive rats and rats pre-
viously exposed to the drug. However, this cannot
explain the divergent response found, for example in
the cingulate cortex, where an MDMA-induced de-
crease in drug-naive rats is replaced by a signiﬁcant
MDMA-induced increase in rats previously exposed
to the drug.
The acute anti-aggressive eﬀects of 5-HT1B agonists
in drug-naive rats were more selective than those of
MDMA, namely, changes in impulsive and aggressive
behaviours such as biting, boxing, kicking were very
marked. Furthermore, the eﬀects of 5-HT1B agonists on
motor activation and exploratory behaviour induced
by the presence of the intruder animal were quite dif-
ferent from those of MDMA, such that 5-HT1B agonists
caused increases in this motor activation, while
MDMA caused a reduction. 5-HT1B agonists evoked
generally similar eﬀects in MDMA-pretreated rats,
compared to drug-naive rats. These data do not,
therefore, indicate a signiﬁcant sensitization of 5-HT1B
receptor function as a consequence of a long-term
serotonergic depletion. A possible explanation is that
despite the partial axonal loss, some, or all, of the
serotonergic axons and terminals involved in anti-
aggressive behaviour may remain intact. Furthermore,
5-HT1B receptors involved in this action may be
located post-synaptically (Barnes and Sharp, 1999 ;
Clark and Neumaier, 2001; Scearce-Levie et al., 1999b)
or are heteroreceptors, located not only on sero-
tonergic terminals, but also on terminals where they
might inhibit the release of other neurotransmitters
including GABA, acetylcholine or glutamate (Clark
and Neumaier, 2001 ; Sexton et al., 1999). Alternatively,
there is the possibility that non-serotonergic mechan-
isms are also involved in the acute eﬀects of MDMA
upon aggression, including dopamine, glutamate or
GABA (Sexton et al., 1999). It is also possible that anx-
iety, reactivity and impulsivity confound the overt
behavioural expression of MDMA-induced eﬀects,
as has previously been described after partial 5-HT
depletion (Green et al., 2003; Harro, 2002). There
was, however, a diﬀerence in drug-induced motor
activation. The increase in locomotor activity and ex-
ploration was signiﬁcantly enhanced in MDMA pre-
treated rats, suggesting that the involvement of 5-HT1B
receptors in locomotor activation diﬀers from that in
the regulation of aggression and impulsivity.
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In conclusion, acute MDMA administration abol-
ished aggressive behaviour in the resident-intruder
test as expected. Unexpectedly, MDMA pretreatment
and the consequent depletion of serotonergic ter-
minals did not increase aggression. This may be ex-
plained by the confounding eﬀects of social isolation,
which is known to induce decrease in brain 5-HT
concentration. Thus, the lack of increase in aggression
may be explained by the neurochemical eﬀects of
social isolation that might be similar to the long-term
eﬀects exerted by MDMA. This suggestion is also
supported by the fact that a previous exposure to
MDMA failed to aﬀect 5-HT1B receptor function in
these animals.
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